Rentabilitas dodolan miturut bathi resik Harpoon Therapeutics, Inc. (HARP)

Tandha merek Harpoon Therapeutics (HARP)

Harpoon Therapeutics develops high-precision antibodies to combat solid tumors by making the disease visible to the immune system. The strategy is based on establishing patent protection with long-term monetization. Within Merck, the company is developing trispecific drugs. The net profit margin demonstrates the business's resilience to shocks, with the indicator reaching -81.70, signaling the current profit trend.

HARP: Rentabilitas resik perusahaan Harpoon Therapeutics Corp 04.07.2022 - 16.03.2024

Rincian analitis perusahaan Harpoon Therapeutics

Ringkesan analitik perusahaan:harpoontx.com - HARP
Barang unggulan Harpoon Tx

The integration of Harpoon Therapeutics (HARP) oncology assets into the Merck structure minimized FDA operational risks. Sales margin measures the share of net profit in revenue, determining the efficiency of converting income into real capital. The dynamics of this ratio reveal the business's hidden margin of safety during periods of turbulence. Daily monitoring allows for the distinction between temporary drawdowns and a systemic crisis. Net profit margin analysis helps investors avoid premature loss crystallization.

Analisis pesaing

NantKwest (IBRX) - Margin resik|Margin resik Immunocore PLC (IMCR)|Rentabilitas dodolan miturut bathi resik JANX|RCUS - Tingkat bathi miturut bathi resik|Rentabilitas dodolan miturut bathi resik ZYME (Zymeworks Corp)|Rentabilitas resik perusahaan TNGX|Margin dodolan resik IOVA (Iovance Biotherapeutics, Inc.)|Tingkat bathi resik IMTX|xencor.com - Margin dodolan resik|Margin resik Compass Therapeutics Corp|Replimune Group, Inc. (REPL) - Margin resik|Lyell Immunopharma - Tingkat bathi resik|IPHA (innate-pharma.com) - Margin dodolan resik|Margin dodolan resik pyxisoncology.com|Margin resik cgen.com (CGEN)|IOBT: Margin bathi resik|Sutro Biopharma Inc. - Rentabilitas dodolan miturut bathi resik|minktherapeutics.com (INKT) - Margin resik|HOWL: Rentabilitas dodolan miturut bathi resik|Margin dodolan perusahaan Immix Biopharma IMMX|ALX Oncology (ALXO) - Margin resik|Margin resik Cue Biopharma, Inc. (CUE)|Margin resik PDS Biotechnology Corporation|Rentabilitas dodolan resik SONN (sonnetbio.com)|Margin dodolan resik MAIA|Margin dodolan perusahaan Liminatus Pharma Inc.|LAVA Therapeutics N.V. - Rentabilitas dodolan miturut bathi resik|NXTC - Rentabilitas dodolan miturut bathi resik|LPTX: Rentabilitas dodolan miturut bathi resik|Margin dodolan perusahaan intensitytherapeutics.com INTS|SNSE (Sensei Bio) - Rentabilitas dodolan miturut bathi resik|Synthetic Biologics (TOVX) - Margin dodolan resik|Margin resik Gritstone bio|Rentabilitas dodolan miturut bathi resik Kineta, Inc. (KA)|Margin dodolan resik NEXI|TSBX - Margin resik|Margin dodolan resik VCNX (Vaccinex Inc.)